Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Hikal Limited

Hikal partners with pharmaceuticals, life sciences, biotechnology, agrochemicals, and specialty chemicals companies to deliver active ingredients, intermediates, and R&D services.

msh id	COM:HIKAL
symbol	HIKAL
name	Hikal Limited
homepage url	https://www.hikal.com
country	IN
sector	Healthcare
industry	Drug Manufacturers - Specialty & Generic
market	STOCKS
employee count	2.14K
crunchbase url	-
linkedin url	-
founders	-

market cap	515.92M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	5.86K
monthly webtraffic growth	0.09
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.1
growth cost of revenue	0.07
growth depreciation and amortization	0.14
growth ebitda	-0.23
growth ebitda ratio	-0.26
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.34
growth gross profit	0.01
growth gross profit ratio	-0.03

COM:HIKAL

Hikal

Last Close

386.70

22/11 07:20

Market Cap

43.38B

Beta: -

Volume Today

182.51K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	201.34M
cost of revenue	201.34M
depreciation and amortization	11.46M
ebitda	40.75M
ebitda ratio	0.18
eps	0.16
eps diluted	0.16
operating expenses	77.59M
operating income	29.29M
operating income ratio	0.13

accounts receivables	-800.61K
capital expenditure	-36.24M
cash at beginning of period	1.37M
cash at end of period	3.2M
inventory	39.4M
working capital ttm	1.95B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-